Xenon Pharmaceuticals XENE Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's change in other assets?
- Xenon Pharmaceuticals (XENE) reported change in other assets of $1.48M in Q1 2026.
- How has Xenon Pharmaceuticals's change in other assets changed year-over-year?
- Xenon Pharmaceuticals's change in other assets increased by 60.0% year-over-year, from $926K to $1.48M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.